Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Plummer

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Critical Care Medicine|September 17, 2016
Pantoprazole or Placebo for Stress Ulcer Prophylaxis (POP-UP): Randomized Double-Blind Exploratory StudyShane P Selvanderan, Matthew J Summers, Mark E Finnis, et al.
Plos One|October 26, 2022
Machine learning predicts the short-term requirement for invasive ventilation among Australian critically ill COVID-19 patientsRoshan Karri, Yi-Ping Phoebe Chen, Aidan J C Burrell, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|December 5, 2017
Long-term mortality of critically ill patients with diabetes who survive admission to the intensive care unitYasmine Ali Abdelhamid, Mark P Plummer, Mark E Finnis, et al.
Journal of Clinical Anesthesia|March 28, 2025
The effects of sodium-glucose transporter 2 inhibition on cardiac surgery-associated acute kidney injury: An open-label randomized pilot studyLars I P Snel, Maartina J P Oosterom-Eijmael, Elena Rampanelli, et al.
Endocrinology|November 21, 2024
Physiology and Pharmacology of Effects of GLP-1-based Therapies on Gastric, Biliary and Intestinal MotilityRyan J Jalleh, Chinmay S Marathe, Christopher K Rayner, et al.
The Journal of Clinical Endocrinology and Metabolism|October 17, 2024
Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and TirzepatideRyan J Jalleh, Mark P Plummer, Chinmay S Marathe, et al.
Scientific Reports|June 25, 2026
Intravenous megadose sodium ascorbate normalises elevations in intracranial pressure and restores pressor responsiveness to norepinephrine in ovine Gram-negative sepsisMaya S Bishop, Ruslan V Pustovit, Alemayehu H Jufar, et al.
Intensive Care Medicine|April 25, 2014
Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortalityMark P Plummer, Rinaldo Bellomo, Caroline E Cousins, et al.
Acta Anaesthesiologica Scandinavica|June 22, 2025
Cardiovascular Outcomes of Perioperative Sodium-Glucose Transporter 2 Inhibition in Cardiac Surgery Patients: An Open-Label Randomized Pilot StudyLars I P Snel, Maartina J P Oosterom-Eijmael, Yugeesh R Lankadeva, et al.
Intensive Care Medicine Experimental|July 8, 2024
Effects of sodium-glucose transporter-2 inhibition on systemic hemodynamics, renal function, and intra-renal oxygenation in sepsis-associated acute kidney injuryAbraham H Hulst, Connie P C Ow, Clive N May, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Critical Care Medicine|September 17, 2016
Pantoprazole or Placebo for Stress Ulcer Prophylaxis (POP-UP): Randomized Double-Blind Exploratory StudyShane P Selvanderan, Matthew J Summers, Mark E Finnis, et al.
Plos One|October 26, 2022
Machine learning predicts the short-term requirement for invasive ventilation among Australian critically ill COVID-19 patientsRoshan Karri, Yi-Ping Phoebe Chen, Aidan J C Burrell, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|December 5, 2017
Long-term mortality of critically ill patients with diabetes who survive admission to the intensive care unitYasmine Ali Abdelhamid, Mark P Plummer, Mark E Finnis, et al.
Journal of Clinical Anesthesia|March 28, 2025
The effects of sodium-glucose transporter 2 inhibition on cardiac surgery-associated acute kidney injury: An open-label randomized pilot studyLars I P Snel, Maartina J P Oosterom-Eijmael, Elena Rampanelli, et al.
Endocrinology|November 21, 2024
Physiology and Pharmacology of Effects of GLP-1-based Therapies on Gastric, Biliary and Intestinal MotilityRyan J Jalleh, Chinmay S Marathe, Christopher K Rayner, et al.
The Journal of Clinical Endocrinology and Metabolism|October 17, 2024
Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and TirzepatideRyan J Jalleh, Mark P Plummer, Chinmay S Marathe, et al.
Scientific Reports|June 25, 2026
Intravenous megadose sodium ascorbate normalises elevations in intracranial pressure and restores pressor responsiveness to norepinephrine in ovine Gram-negative sepsisMaya S Bishop, Ruslan V Pustovit, Alemayehu H Jufar, et al.
Intensive Care Medicine|April 25, 2014
Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortalityMark P Plummer, Rinaldo Bellomo, Caroline E Cousins, et al.
Acta Anaesthesiologica Scandinavica|June 22, 2025
Cardiovascular Outcomes of Perioperative Sodium-Glucose Transporter 2 Inhibition in Cardiac Surgery Patients: An Open-Label Randomized Pilot StudyLars I P Snel, Maartina J P Oosterom-Eijmael, Yugeesh R Lankadeva, et al.
Intensive Care Medicine Experimental|July 8, 2024
Effects of sodium-glucose transporter-2 inhibition on systemic hemodynamics, renal function, and intra-renal oxygenation in sepsis-associated acute kidney injuryAbraham H Hulst, Connie P C Ow, Clive N May, et al.
Pageof 11